Terms: = Sarcomas AND EWSR1, EWS, 2130, ENSG00000182944 AND Treatment
478 results:
1. Elucidating the Diagnostic Complexity of Round Cell Sarcoma with ewsr1-CREM Fusion: A Comprehensive Case Study.
Yen H; Chou JL; Li YF; Wang DS
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674190
[TBL] [Abstract] [Full Text] [Related]
2. Abdominopelvic desmoplastic small round cell tumor with metastasis: A case report and literature review.
Chen G; Zhang Q; Xia D
Medicine (Baltimore); 2024 Apr; 103(14):e37664. PubMed ID: 38579065
[TBL] [Abstract] [Full Text] [Related]
3. Ewing's sarcoma in adolescents and adults - 10-year experience from a tertiary cancer center in India.
Narayanan G; Kamala LH; Nair SG; Purushothaman PN; Kumar A; Kattoor J
J Cancer Res Ther; 2024 Jan; 20(1):79-84. PubMed ID: 38554302
[TBL] [Abstract] [Full Text] [Related]
4. Primary pulmonary myxoid sarcoma with ewsr1::CREB1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H
J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
[TBL] [Abstract] [Full Text] [Related]
5. Novel KMT2B gene mutation in MUC4 positive low-grade fibromyxoid sarcoma.
Zhang L; Luo L; Liu C; Li Z
Diagn Pathol; 2024 Feb; 19(1):30. PubMed ID: 38347522
[TBL] [Abstract] [Full Text] [Related]
6. A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug
Sabnis N; Raut S; Nagarajan B; Kapic A; Dossou AS; Lothstein L; Fudala R; Bunnell BA; Lacko AG
Bioconjug Chem; 2024 Feb; 35(2):187-202. PubMed ID: 38318778
[TBL] [Abstract] [Full Text] [Related]
7. Report and literature review of four cases of ewsr1::NFATC2 round cell sarcoma.
Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
[TBL] [Abstract] [Full Text] [Related]
8. Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database.
Braaten M; Braaten J; Chaddha J; Hu R; Lanoue C; Silberstein P; Tauseef A; Asghar N; Mirza M
Eur J Med Res; 2024 Jan; 29(1):29. PubMed ID: 38183148
[TBL] [Abstract] [Full Text] [Related]
9. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or ewsr1-TFCP2 fusions.
Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
[TBL] [Abstract] [Full Text] [Related]
10. The DNA/RNA helicase DHX9 orchestrates the KDM2B-mediated transcriptional regulation of YAP1 in Ewing sarcoma.
Chellini L; Scarfò M; Bonvissuto D; Sette C; Paronetto MP
Oncogene; 2024 Jan; 43(4):225-234. PubMed ID: 38017132
[TBL] [Abstract] [Full Text] [Related]
11. The Chromatin Remodeler CHD4 Sustains Ewing Sarcoma Cell Survival by Controlling Global Chromatin Architecture.
Graca Marques J; Pavlovic B; Ngo QA; Pedot G; Roemmele M; Volken L; Kisele S; Perbet R; Wachtel M; Schäfer BW
Cancer Res; 2024 Jan; 84(2):241-257. PubMed ID: 37963210
[TBL] [Abstract] [Full Text] [Related]
12. Desmoplastic small round cell tumor of the abdomen: A case report.
Li R; Liu W; Ye L
Medicine (Baltimore); 2023 Nov; 102(45):e35965. PubMed ID: 37960784
[TBL] [Abstract] [Full Text] [Related]
13. Oncomeric Profiles of microRNAs as New Therapeutic Targets for treatment of Ewing's Sarcoma: A Composite Review.
Hassan M; Shahzadi S; Malik A; Din SU; Yasir M; Chun W; Kloczkowski A
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895198
[TBL] [Abstract] [Full Text] [Related]
14. ews/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.
Yasir M; Park J; Chun W
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894854
[TBL] [Abstract] [Full Text] [Related]
15. Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.
Phadnis S; Wang X; Daw NC; Herzog CE; Subbiah IM; Zaky W; Gouda MA; Morani AC; Amini B; Harrison DJ; Piha-Paul SA; Meric-Bernstam F; Gorlick R; Schwartz CL; Subbiah V
ESMO Open; 2023 Dec; 8(6):101609. PubMed ID: 37879233
[TBL] [Abstract] [Full Text] [Related]
16. Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman.
Asif S; Hurley BJ; Haroon S; Lele S; Sharma B
Oncology (Williston Park); 2023 Oct; 37(10):412-416. PubMed ID: 37877807
[TBL] [Abstract] [Full Text] [Related]
17. Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.
Koch R; Haveman L; Ladenstein R; Brichard B; Jürgens H; Cyprova S; van den Berg H; Hassenpflug W; Raciborska A; Ek T; Baumhoer D; Egerer G; Kager L; Renard M; Hauser P; Burdach S; Bovee JVMG; Hong AM; Reichardt P; Kruseova J; Streitbürger A; Kühne T; Kessler T; Bernkopf M; Butterfaß-Bahloul T; Dhooge C; Bauer S; Kiss J; Paulussen M; Bonar F; Ranft A; Timmermann B; Rascon J; Vieth V; Kanerva J; Faldum A; Hartmann W; Hjorth L; Bhadri VA; Metzler M; Gelderblom H; Dirksen U
Clin Cancer Res; 2023 Dec; 29(24):5057-5068. PubMed ID: 37843857
[TBL] [Abstract] [Full Text] [Related]
18. Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
Peretz Soroka H; Vora T; Noujaim J; Marcoux N; Cohen-Gogo S; Alcindor T; Holloway C; Rodrigues C; Karachiwala H; Alvi S; Lee U; Cheng S; Banerji S; Oberoi S; Feng X; Smrke A; Simmons C; Razak AA; Gupta AA
Cancer Med; 2023 Sep; 12(18):18872-18881. PubMed ID: 37724607
[TBL] [Abstract] [Full Text] [Related]
19. Clinical features and outcomes of infantile soft-tissue sarcoma: A multicenter retrospective study in Beijing.
Zhu S; Xu N; Zhi T; Gao Y; Zhong D; Zhang W; Jin M; Sun Q; Xie Y; Zhang X; Li L; Wang S; Wang H; Liu R; Zhao W; Huang D; Ni X; Ma X
J Cancer Res Ther; 2023 Aug; 19(4):876-880. PubMed ID: 37675711
[TBL] [Abstract] [Full Text] [Related]
20. Intraosseous Spindle Cell Rhabdomyosarcoma with
Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
[TBL] [Abstract] [Full Text] [Related]
[Next]
